FDA Drug Application (207768) for TUZISTRA XR by VERNALIS R AND D LTD

Back to FDA Applications sponsored by VERNALIS R AND D LTD

Application Number207768
Product Number001
FormSUSPENSION, EXTENDED RELEASE;ORAL
DosageEQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTUZISTRA XR
Active IngredientCHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX

Active IngredientCount
List of drugs with Active Ingredient CHLORPHENIRAMINE POLISTIREX8
List of drugs with Active Ingredient CODEINE POLISTIREX3


Back to FDA Applications sponsored by VERNALIS R AND D LTD